PRESS RELEASE published on 02/25/2026 at 15:52, 6 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc The Vanguard Group, Inc. discloses 0.94% ownership in Life Science REIT plc. Purchase of 8,430 securities at 0.42 GBP per unit on 24 February 2026 Securities Vanguard Group Purchase Ownership Life Science REIT Plc
PRESS RELEASE published on 02/25/2026 at 15:51, 6 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.61% stake in Spire Healthcare Group plc, along with recent purchase of 1p ordinary shares. No other disclosures made The Vanguard Group Stock Purchase Financial Disclosure Stake Disclosure Spire Healthcare Group Plc
PRESS RELEASE published on 02/25/2026 at 15:50, 6 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 4.92% ownership in Just Group plc according to Form 8.3 submission under the Takeover Code Form 8.3 The Vanguard Group Takeover Code Ownership Disclosure Just Group Plc
PRESS RELEASE published on 02/25/2026 at 15:50, 6 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.30% stake in LondonMetric Property plc on 24 Feb 2026, with 79,820 securities purchased at 2.11 GBP per unit Securities LondonMetric Property Plc Vanguard Group Ownership Disclosure Purchase
PRESS RELEASE published on 02/25/2026 at 15:50, 6 months 13 days ago DÉCLARATION D'ACTIONS ET NOMBRE DE DROITS DE VOTE AU 31 JANVIER 2026 Eagle Football Group communique les chiffres clés de droits de vote conformément aux régulations de l'Autorité des Marchés Financiers Autorité Des Marchés Financiers Euronext Paris Droits De Vote Eagle Football Group CAC All-Share
PRESS RELEASE published on 02/25/2026 at 15:50, 6 months 13 days ago DISCLOSURE OF TOTAL NUMBER OF VOTING RIGHTS AND NUMBER OF SHARES IN THE CAPITAL AT JANUARY 31, 2026 EAGLE FOOTBALL GROUP total shares and voting rights disclosure under French regulations. Contact for more info Voting Rights Shares French Regulations Eagle Football Group Contact
PRESS RELEASE published on 02/25/2026 at 15:49, 6 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses a 5.24% interest in Picton Property Income Limited. Dealings include 17,914 securities purchased at 0.87 GBP Financial Dealings The Vanguard Group Securities Purchase Interest Disclosure Picton Property Income Limited
PRESS RELEASE published on 02/25/2026 at 15:48, 6 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 4.83% ownership in NCC Group plc. Form 8.3 filing made on 25-Feb-2026 regarding relevant securities Securities Form 8.3 The Vanguard Group Ownership Disclosure NCC Group Plc
PRESS RELEASE published on 02/25/2026 at 15:47, 6 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The The Vanguard Group, Inc. discloses a 5.45% stake in British Land Company plc. Purchase of 34,210 25p ordinary shares at 4.09 GBP per unit Stock Purchase Vanguard Group Financial Disclosure British Land Company 5.45% Stake
PRESS RELEASE published on 02/25/2026 at 15:43, 6 months 13 days ago Original-Research: INDUS Holding AG (von Parmantier & Cie. GmbH): Buy Parmantier & Cie. GmbH updates rating for INDUS Holding AG to Buy with a target price of €35.00, highlighting strong 2025 performance and acquisitions in Engineering segment BUY Rating INDUS Holding AG Parmantier & Cie. GmbH 2025 Performance Engineering Acquisitions
Published on 09/11/2026 at 04:00, 3 hours 14 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 8 hours 49 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 15 hours 54 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 16 hours 14 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 00:05, 7 hours 9 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 00:01, 7 hours 13 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/10/2026 at 22:39, 8 hours 34 minutes ago EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:10, 9 hours 3 minutes ago flatexDEGIRO with changes to the Supervisory Board
Published on 09/10/2026 at 22:07, 9 hours 7 minutes ago EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board
Published on 09/11/2026 at 07:00, 14 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 14 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 11 hours 44 minutes ago Availability of the 2026 Interim Financial Report
